Another example for the prognostic value of CTCs in MBCs determined by not only the epithelial marker EpCAM, but also by markers for the EMT-feature and stem cell feature was presented in 2021 [177]. This evidence concerns the gene EPCAM and maternal uniparental disomy of chromosome 20.